Literature DB >> 1967008

Role of surgery in the management of pituitary tumors.

C B Wilson1.   

Abstract

Growth characteristics and size, irrespective of endocrine activity, predict the nonendocrine clinical presentation of a pituitary adenoma. Anatomic classification by degree of sellar destruction (grade) and extrasellar extension (stage) has value in determining prognosis and in designing therapy, and magnetic resonance imaging provides optimal diagnostic information. The transsphenoidal approach is the preferred surgical technique for most pituitary adenomas and the treatment of choice for those secreting growth hormone (acromegaly) or adrenocorticotropic hormone (Cushing's disease, Nelson's syndrome) and certain nonsecreting tumors. Opinions differ on the initial treatment for prolactin-secreting adenomas; whether most patients should be treated medically or surgically and whether bromocriptine or irradiation should be reserved for surgical failures are still being debated. From experience in a series of 1813 pituitary adenomas, the author surveys tumors of the pituitary region and the role surgery plays in their management.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967008

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  8 in total

Review 1.  Diagnosis and management of pituitary tumours.

Authors:  A Levy; S L Lightman
Journal:  BMJ       Date:  1994-04-23

2.  Acromegaly: surgical results in 548 patients.

Authors:  Cecilia Fernández Mateos; Maria García-Uria; Tomás Lucas Morante; José García-Uría
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

3.  Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.

Authors:  S S Damjanović; V P Popović; M S Petakov; M M Nikolic-Durović; M Z Doknić; M S Gligorović
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

Review 4.  Molecular pathogenesis of acromegaly.

Authors:  M R Drange; S Melmed
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

5.  KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.

Authors:  Marianna Yaron; Ulrich Renner; Suzan Gilad; Günter K Stalla; Naftali Stern; Yona Greenman
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

Review 6.  Pituitary adenomas in childhood.

Authors:  S K Singh; Rohit Aggarwal
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

7.  Assessment of Mitotic Activity in Pituitary Adenomas and Carcinomas.

Authors:  Kamal Thapar; Yukio Yamada; Bernd Scheithauer; Kalman Kovacs; Shozo Yamada; Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

8.  Clinical study of endoscopic treatment of a sellar pituitary adenomas with sellar diaphragm defect.

Authors:  Zhuoru Jin; Xinyu Wu; Yibao Wang
Journal:  BMC Neurol       Date:  2020-04-11       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.